Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation

Endocrinology

Volumn 150, Issue 7, 2009, Pages 3177-3185

  Luque, Raul M ^a,b   Soares, Beatriz S ^a,d   Peng, Xiao Ding ^a   Krishnan, Sonia ^a   Cordoba Chacon, Jose ^a,b   Frohman, Lawrence A ^a   Kineman, Rhonda D ^a,c  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CÓRDOBA   (Spain)

^c JESSE BROWN VA MEDICAL CENTER   (United States)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; INTERLEUKIN 1BETA CONVERTING ENZYME; KI 67 ANTIGEN; MESSENGER RNA; METALLOTHIONEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 2; PROTEIN P27; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 5; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL AGING; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL LABELING; CONTROLLED STUDY; GENE EXPRESSION; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING ADENOMA; HYPERPLASIA; HYPOPHYSIS DISEASE; MALE; MOUSE; NONHUMAN; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PITUITARY HYPERPLASIA; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOMA; AGING; ANIMALS; CELL PROLIFERATION; FEMALE; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; MALE; METALLOTHIONEIN; MICE; MICE, KNOCKOUT; ORGAN SIZE; PITUITARY GLAND; PITUITARY NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; RNA, MESSENGER; SOMATOSTATIN; SOMATOTROPHS;

EID: 67649648242     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1482     Document Type: Article

References (40)

1. Mayo KE, Miller TL, DeAlmeida V, Zheng J, Godfrey PA 1996 The growth-hormone-releasing hormone receptor: signal transduction, gene expression and physiological function in growth regulation. Ann NY Acad Sci 805:184-203 (Pubitemid 27058021)
2. Frohman LA, Kineman RD 1999 Growth hormone-releasing hormone: discovery, regulation, and actions. In: Kostyo J, ed. Handbook of physiology: hormonal control of growth. New York: Oxford University Press; 189-221
3. Billestrup N, Swanson LW, Vale W 1986 Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA 83:6854-6857 (Pubitemid 16002331)
4. Thorner MO, Frohman LA, Leong DA, Thominet J, Downs T, Hellman P, Chitwood J, Vaughan JM, Vale W 1984 Extra-hypothalamic growth hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in l77 acromegalic patients. J Clin Endocrinol Metab 59:846-849 (Pubitemid 14020682)
5. Sano T, Asa SL, Kovacs K 1988 Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 9:357-373
6. Ezzat S, Asa SL, Stefaneanu L, Whittom R, Smyth HS, Horvath E, Kovacs K, Frohman LA 1994 Somatotroph hyperplasia without pituitary adenoma associated with a longstanding GHRH-producing bronchial carcinoid tumor. J Clin Endocrinol Metab 78:555-560
7. Saeger W, Puchner MJ, Lüdecke DK 1994 Combined sellar gangliocytoma and pituitary adenoma in acromegaly or Cushing's disease. A report of 3 cases. Virchows Arch 425:93-99 (Pubitemid 24295513)
8. Thapar K, Kovacs K, Stefaneanu L, Scheithauer B, Killinger DW, Lloyd RV, Smyth HS, Barr A, Thorner MO, Gaylinn B, Laws Jr ER 1997 Overexpression of the growth-hormone-releasing hormone gene in acromegaly-associated pituitary tumors. An event associated with neoplastic progression and aggressive behavior. Am J Pathol 151:769-784 (Pubitemid 27385609)
9. Wakabayashi I, Inokuchi K, Hasegawa O, Sugihara H, Minami S 1992 Expression of growth hormone (GH)-releasing factor gene in GH-producing pituitary adenoma. J Clin Endocrinol Metab 74:357-361
10. Horvath A, Stratakis CA 2008 Clinical and molecular genetics of acromegaly: MEN1, Carney complex, McCune-Albright syndrome, familial acromegaly and genetic defects in sporadic tumors. Rev Endocr Metab Disord 9:1-11
11. Bertherat J, Chanson P, Montminy M 1995 The cyclic adenosine 3′,5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Mol Endocrinol 9:777-783
12. Pack SD, Kirschner LS, Pak E, Zhuang Z, Carney JA, Stratakis CA 2000 Genetic and histologic studies of somatomammotropic pituitary tumors in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity and Schwannomas" (Carney Complex). J Clin Endocrinol Metab 85:3860-3865
13. Yin Z, Williams-Simons L, Parlow AF, Asa S, Kirschner LS 2008 Pituitary-specific knockout of the Carney Complex gene Prkar1a leads to pituitary tumorigenesis. Mol Endocrinol 22:380-387 (Pubitemid 351185937)
14. Hammer RE, Brinster RL, Rosenfeld MG, Evans RM, Mayo KE 1985 Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature 315:413-416 (Pubitemid 15031551)
15. Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM 1988 Dramatic pituitary hyperplasia in transgenic mice expressing a human growth hormone-releasing factor gene. Mol Endocrinol 2:606-612 (Pubitemid 18174444)
16. Stefaneanu L, Kovacs K, Horvath E, Asa SL, Losinski NE, Billestrup N, Price J, Vale W 1989 Adenohypophysial changes in mice transgenic for human growth hormone-releasing factor: a histological, immunocytochemical, and electron microscopic investigation. Endocrinology 125:2710-2718 (Pubitemid 19279463)
17. Lloyd RV, Jin L, Chang A, Kulig E, Camper SA, Ross BD, Downs TR, Frohman LA 1992 Morphologic effects of hGRH gene expression on the pituitary, liver, and pancreas of MT-hGRH transgenic mice. An in situ hybridization analysis. Am J Pathol 141:895-906
18. Kineman RD, Teixeira LT, Amargo GV, Coschigano KT, Kopchick JJ, Frohman LA 2001 The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling. Endocrinology 142:3764-3773 (Pubitemid 32802647)
19. Teixeira LT, Kiyokawa H, Peng X-D, Christov KT, Frohman LA, Kineman RD 2000 p27(Kip1)-deficient mice exhibit accelerated growth hormone-releasing hormone-induced somatotrope proliferation and adenoma formation. Oncogene 19:1875-1884 (Pubitemid 30219030)
20. Zeyda T, Diehl N, Paylor R, Brennan MB, Hochgeschwender U 2001 Impairment in motor learning of somatostatin null mutant mice. Brain Res 906:107-117 (Pubitemid 32595544)
21. Luque RM, Kineman RD 2007 Gender-dependent role of endogenous somatostatin in regulating growth hormone (GH)-axis function in mice. Endocrinology 148:5998-6006 (Pubitemid 350146151)
22. McGinley JN, Knott KK, Thompson HJ 2000 Effect of fixation and epitope retrieval on BrdU indices in mammary carcinomas. J Histochem Cytochem 48:355-362 (Pubitemid 30131682)
23. Luque RM, Gahete MD, Hochgeschwender U, Kineman RD 2006 Evidence that endogenous somatostatin (SST) inhibits adrenocorticotropin (ACTH) and ghrelin expression by independent pathways. Am J Physiol Endocrinol Metab 291:E395-E403
24. Kineman RD, Kamegai J, Frohman LA 1999 Growth hormone-releasing hormone (GHRH) and the growth hormone secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor (GHS-R) and GHRH receptor (GHRH-R) mRNA levels. Endocrinology 140:3581-3586
25. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F 2002 Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biology 3:research0034
26. Jirawatnotai S, Aziyu A, Osmundson EC, Moons DS, Zou X, Kineman RD, Kiyokawa H 2004 Cdk4 is indispensable for postnatal proliferation of the anterior pituitary J Biol Chem 279:51100-51106
27. McCabe CJ, Gittoes NJL, Sheppard MC, Franklyn JA 1999 Increased MEN1 mRNA expression in sporadic pituitary tumors. Clin Endocrinol (Oxf) 50:727-733 (Pubitemid 29284506)
28. Lytras A, Tolis G 2006 Growth hormone-secreting tumors: genetic aspects and data from animal models. Neuroendocrinology 83:166-178 (Pubitemid 44578869)
29. Peng X-D, Park S, Gadelha MR, Coschigano KT, Kopchick JJ, Frohman LA, Kineman RD 2001 The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback. Endocrinology 142:1117-1123 (Pubitemid 32202821)
30. Lopes MB, Gaylinn BD, Thorner MO, Stoler MH 1997 Growth hormone-releasing hormone receptor mRNA in acromegalic pituitary tumors. Am J Pathol 150:1885-1891 (Pubitemid 27233061)
31. Oka H, Kameya T, Sato Y, Naritaka H, Kawano N 1999 Significance of growth hormone-releasing hormone receptor mRNA in non-neoplastic pituitary and pituitary adenomas: a study by RT-PCR and in situ hybridization. J Neurooncol 41:197-204 (Pubitemid 29209807)
32. Lania A, Persani L, Ballaré E, Mantovani S, Losa M, Spada A 1998 Constitutively active Gsα is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas. J Clin Endocrinol Metab 83:1624-1628 (Pubitemid 28501033)
33. Tentler JJ, Hadcock JR, Gutierrez-Hartmann A 1998 Somatostatin acts by inhibiting the cyclic 3′, 5′-adenosine monophosphate (cAMP)/protein kinase A pathway, cAMP response element-binding protein (CREB) phosphorylation, and CREB transcription potency. Mol Endocrinol 11:859-866
34. Ferjoux G, Bousquet C, Cordelier P, Benali N, Lopez F, Rochaix P, Buscail L, Susini C 2000 Signal transduction of somatostatin receptors negatively controlling cell proliferation. J Physiol 94:205-210 (Pubitemid 30847791)
35. Bilezikjian LM, Vale WW 1983 Stimulation of adenosine 3′,5′-monophosphate production by growth hormone-releasing factor and its inhibition by somatostatin in anterior pituitary cells in vitro. Endocrinology 113:1726-1731
36. 1 cell cycle block. Endocrinology 136:4174-4181
37. Bevan JS, Melmed S 2005 The antitumoral effects of somatostatin analog therapy in acromegaly. J Clin Endocrinol Metab 90:1856-1863 (Pubitemid 40464061)
38. Melmed S, Sternberg R, Cook D, Kilbanski A, Chanson P, Bonert V, Vance ML, Rhew D, Kleinberg D, Barkan A 2005 A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly. J Clin Endocrinol Metab 90:4405-4410 (Pubitemid 41058228)
39. Grant M, Alturaihi H, Jaquet P, Collier B, Kumar U 2008 Cell growth inhibition and functioning of human somatostatin receptor type 2 are modulated by receptor heterodimerization. Mol Endocrinol 22:2278-2292
40. Day R, Dong W, Panetta R, Kracier J, Greenwood MT, Patel YC 1995 Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis. Endocrinology 136:5232-5235